These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9043898)

  • 1. Assessment of bioequivalence after subcutaneous and intramuscular administration of urinary gonadotrophins.
    Huisman JA; Paulussen RJ; Geurts TB; Odink J; Rekers H
    Hum Reprod; 1997 Jan; 12(1):34-8. PubMed ID: 9043898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of two human menopausal gonadotrophin preparations after single intravenous administration during pituitary suppression.
    Duijkers IJ; Beerens MC; Coelingh Bennink HJ; Huisman JA; Rombout F; Vemer HM
    Hum Reprod; 1995 Jun; 10(6):1367-72. PubMed ID: 7593498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and Pharmacodynamics of Follicle-Stimulating Hormone in Healthy Women Receiving Single and Multiple Doses of Highly Purified Human Menotrophin and Urofollitrophin.
    Di Stefano AF; Rusca A; Radicioni MM; Loprete L; Binelli D; Caccia G; Cometti B
    Clin Drug Investig; 2016 Dec; 36(12):1031-1044. PubMed ID: 27638053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics and pharmacokinetics after repeated subcutaneous administration of three gonadotrophin preparations.
    Duijkers IJ; Klipping C; Mulders TM; Out HJ; Coelingh Bennink HJ; Vemer HM
    Hum Reprod; 1997 Nov; 12(11):2379-84. PubMed ID: 9436668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence of subcutaneous injections of recombinant human follicle stimulating hormone (Puregon(R)) by Pen-injector and syringe.
    Voortman G; van de Post J; Schoemaker RC; van Gerven JM
    Hum Reprod; 1999 Jul; 14(7):1698-702. PubMed ID: 10402370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence of recombinant human FSH and recombinant human LH in a fixed 2:1 combination: two phase I, randomised, crossover studies.
    Picard M; Rossier C; Papasouliotis O; Lugan I
    Curr Med Res Opin; 2008 Apr; 24(4):1199-208. PubMed ID: 18348746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose proportionality study of subcutaneously and intramuscularly administered recombinant human follicle-stimulating hormone (Follistim*/Puregon) in healthy female volunteers.
    Voortman G; Mannaerts BM; Huisman JA
    Fertil Steril; 2000 Jun; 73(6):1187-93. PubMed ID: 10856481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absorption and uptake of recombinant human follicle-stimulating hormone through vaginal subcutaneous injections--a pharmacokinetic study.
    Hsu CC; Kuo HC; Hsu CT; Gu Q
    Reprod Biol Endocrinol; 2009 Oct; 7():107. PubMed ID: 19807931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity.
    Fleming R; Chung CC; Yates RW; Coutts JR
    Hum Reprod; 1996 Sep; 11(9):1854-8. PubMed ID: 8921053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsatile subcutaneous versus bolus intramuscular gonadotrophin administration after pituitary suppression with a long-acting gonadotrophin-releasing hormone analogue: a controlled prospective study.
    De Geyter C; De Geyter M; Simoni M; Castro E; Bals-Pratsch M; Nieschlag E; Schneider HP
    Hum Reprod; 1994 Jun; 9(6):1070-6. PubMed ID: 7962378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized three-way cross-over study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl) after intramuscular and subcutaneous administration.
    Mannaerts BM; Geurts TB; Odink J
    Hum Reprod; 1998 Jun; 13(6):1461-4. PubMed ID: 9688371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bioequivalence study of two urinary follicle stimulating hormone preparations: Follegon and Metrodin.
    Out HJ; Schnabel PG; Rombout F; Geurts TB; Bosschaert MA; Coelingh Bennink HJ
    Hum Reprod; 1996 Jan; 11(1):61-3. PubMed ID: 8671157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence of liquid and freeze-dried recombinant human follicle-stimulating hormone.
    Lugan I; Febbraro S; Lecuelle H; Papasouliotis O; Ho-Nguyena Q; Buraglio M
    Curr Med Res Opin; 2005 Jan; 21(1):121-5. PubMed ID: 15881483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in serum follicle-stimulating hormone uptake after intramuscular and subcutaneous human menopausal gonadotropin injection.
    Dobbs KE; Dumesic DA; Dumesic JA; Shapiro SS
    Fertil Steril; 1994 Nov; 62(5):978-83. PubMed ID: 7926145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of follicle-stimulating hormone and luteinizing hormone after subcutaneous administration of human menopausal gonadotropin during pituitary suppression.
    Duijkers IJ; Magnusson YM; Hollanders HM
    Int J Fertil Menopausal Stud; 1995; 40(6):307-10. PubMed ID: 8748920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone.
    le Cotonnec JY; Porchet HC; Beltrami V; Munafo A
    Fertil Steril; 1998 Feb; 69(2):189-94. PubMed ID: 9496327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of obesity on recombinant follicle-stimulating hormone absorption: subcutaneous versus intramuscular administration.
    Steinkampf MP; Hammond KR; Nichols JE; Slayden SH
    Fertil Steril; 2003 Jul; 80(1):99-102. PubMed ID: 12849809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitution.
    Jonker DM; Koch M; Larsson P; Ravi A; Buur Rasmussen B; Speer R; Mannaerts B
    Int J Clin Pharmacol Ther; 2021 Dec; 59(12):794-803. PubMed ID: 34622768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers.
    Dychter SS; Harrigan R; Bahn JD; Printz MA; Sugarman BJ; DeNoia E; Haughey DB; Fellows D; Maneval DC
    Clin Ther; 2014 Feb; 36(2):211-24. PubMed ID: 24486335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of two urinary human follicle stimulating hormone preparations in healthy female and male volunteers.
    le Cotonnec JY; Porchet HC; Beltrami V; Howles C
    Hum Reprod; 1993 Oct; 8(10):1604-11. PubMed ID: 8300814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.